Cargando…

MicroRNA involvement in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is the third cause of cancer-related death worldwide. Curative options for HCC are limited and exclusively available for patients carrying an early stage HCC. In advanced stages, traditional chemotherapy proved to be only marginally effective or even toxic. Thus, the i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gramantieri, Laura, Fornari, Francesca, Callegari, Elisa, Sabbioni, Silvia, Lanza, Giovanni, Croce, Carlo M, Bolondi, Luigi, Negrini, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2008
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514099/ https://www.ncbi.nlm.nih.gov/pubmed/19120703 http://dx.doi.org/10.1111/j.1582-4934.2008.00533.x

Ejemplares similares

Role of microRNAs in hepatocellular carcinoma: a clinical perspective
por: Callegari, Elisa, et al.
Publicado: (2013)

Animal Models of Hepatocellular Carcinoma Prevention
por: Shankaraiah, Ram C., et al.
Publicado: (2019)

TP53/MicroRNA Interplay in Hepatocellular Carcinoma
por: Pollutri, Daniela, et al.
Publicado: (2016)

MicroRNAs in Animal Models of HCC
por: Fornari, Francesca, et al.
Publicado: (2019)

Inhibiting the oncogenic mir-221 by microRNA sponge: toward microRNA-based therapeutics for hepatocellular carcinoma
por: Moshiri, Farzaneh, et al.
Publicado: (2014)

Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma
por: Lupini, Laura, et al.
Publicado: (2016)

MicroRNAs as predictive biomarkers of treatment response to tyrosine kinase inhibitors in hepatocellular carcinoma: how much is missing?
por: Gramantieri, Laura, et al.
Publicado: (2022)

MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma
por: Gramantieri, Laura, et al.
Publicado: (2022)

MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma
por: Gramantieri, Laura, et al.
Publicado: (2021)

Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma
por: Moshiri, Farzaneh, et al.
Publicado: (2018)

MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer
por: Callegari, Elisa, et al.
Publicado: (2018)

MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma
por: Turato, Cristian, et al.
Publicado: (2019)

Targeting Notch3 in Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Perspectives
por: Giovannini, Catia, et al.
Publicado: (2016)

LncRNAs as novel players in hepatocellular carcinoma recurrence
por: Gramantieri, Laura, et al.
Publicado: (2018)

Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC
por: Fornari, Francesca, et al.
Publicado: (2015)

Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma
por: Giovannini, Catia, et al.
Publicado: (2014)

Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus
por: Callegari, Elisa, et al.
Publicado: (2013)

The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma
por: Pollutri, Daniela, et al.
Publicado: (2018)

Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research
por: Fornari, Francesca, et al.
Publicado: (2022)

microRNAs and Inflammatory Immune Response in SARS-CoV-2 Infection: A Narrative Review
por: Maranini, Beatrice, et al.
Publicado: (2022)

Corrigendum: Vidatox 30 CH has tumor activating effect in hepatocellular carcinoma
por: Giovannini, Catia, et al.
Publicado: (2017)

Venom from Cuban Blue Scorpion has tumor activating effect in hepatocellular carcinoma
por: Giovannini, Catia, et al.
Publicado: (2017)

miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model
por: Callegari, Elisa, et al.
Publicado: (2018)

mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer
por: Lanza, Giovanni, et al.
Publicado: (2007)

Molecular and proteomic insight into Notch1 characterization in hepatocellular carcinoma
por: Giovannini, Catia, et al.
Publicado: (2016)

miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs
por: Lupini, Laura, et al.
Publicado: (2013)

Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma
por: Giovannini, Catia, et al.
Publicado: (2023)

miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eμ-TCL1 mouse model
por: Bresin, Antonella, et al.
Publicado: (2015)

Medical Treatment of Hepatocellular Carcinoma
por: Granito, Alessandro, et al.
Publicado: (2009)

Notch3 inhibition enhances sorafenib cytotoxic efficacy by promoting GSK3β phosphorylation and p21 down-regulation in hepatocellular carcinoma
por: Giovannini, Catia, et al.
Publicado: (2013)

Involvement of inflammation and its related microRNAs in hepatocellular carcinoma
por: Jin, Ke, et al.
Publicado: (2016)

MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma
por: Bergamini, Christian, et al.
Publicado: (2023)

miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models
por: Callegari, Elisa, et al.
Publicado: (2022)

miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models
por: Callegari, Elisa, et al.
Publicado: (2022)

Novel Virus Identification through Metagenomics: A Systematic Review
por: Bassi, Cristian, et al.
Publicado: (2022)

Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR
por: Mangolini, Alessandra, et al.
Publicado: (2015)

The Molecular Networks of microRNAs and Their Targets in the Drug Resistance of Colon Carcinoma
por: Crudele, Francesca, et al.
Publicado: (2021)

Notch Signaling Regulation in HCC: From Hepatitis Virus to Non-Coding RNAs
por: Giovannini, Catia, et al.
Publicado: (2021)

Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions
por: Fornari, Francesca, et al.
Publicado: (2021)

The role of MicroRNAs in human cancer
por: Peng, Yong, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ktj6870jd5dr847rp145h9pbto